These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 30273566)

  • 21. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
    Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
    J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
    Wei M; Mao S; Lu G; Li L; Lan X; Huang Z; Chen Y; Zhao M; Zhao Y; Xia Q
    BMC Cancer; 2018 Apr; 18(1):434. PubMed ID: 29665787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
    Cheng K; Hao M
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGCG inhibits migration, invasion and epithelial-mesenchymal transition of renal cell carcinoma by activating TFEB-mediated autophagy.
    Liu B; Luo L; Yu B; Que T; Zhang Y
    Chem Biol Interact; 2024 Nov; 403():111250. PubMed ID: 39313106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
    Hsieh MH; Tsai JP; Yang SF; Chiou HL; Lin CL; Hsieh YH; Chang HR
    Cells; 2019 Aug; 8(9):. PubMed ID: 31438640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
    Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
    Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
    Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
    Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cobalt Chloride-induced Hypoxia Induces Epithelial-mesenchymal Transition in Renal Carcinoma Cell Lines.
    Zhang N; Hong B; Zhou C; Du X; Chen S; Deng X; Duoerkun S; Li Q; Yang Y; Gong K
    Ann Clin Lab Sci; 2017 Jan; 47(1):40-46. PubMed ID: 28249915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma.
    Liu Y; Qian J; Li X; Chen W; Xu A; Zhao K; Hua Y; Huang Z; Zhang J; Liang C; Su S; Li P; Shao P; Li J; Qin C; Wang Z
    Oncotarget; 2016 Dec; 7(49):81410-81422. PubMed ID: 27806310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
    Liu Y; Shang D
    Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
    Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
    Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
    Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
    Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.
    Mizumoto A; Yamamoto K; Nakayama Y; Takara K; Nakagawa T; Hirano T; Hirai M
    J Pharmacol Exp Ther; 2015 Nov; 355(2):152-8. PubMed ID: 26306766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
    Kou B; Liu W; Tang X; Kou Q
    Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.
    Leonel C; Ferreira LC; Borin TF; Moschetta MG; Freitas GS; Haddad MR; de Camargos Pinto Robles JA; Aparecida Pires de Campos Zuccari D
    Anticancer Agents Med Chem; 2017; 17(8):1113-1125. PubMed ID: 28042775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.